Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax).
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age
- Status
- COMPLETED
- Phase
- PHASE2
Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)
- Status
- TERMINATED
- Phase
- PHASE1
Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy
- Status
- TERMINATED
- Phase
- PHASE1
Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
- Status
- TERMINATED
- Phase
- PHASE2
Study of Repeat Intranodal Injections of Ad-ISF35
- Status
- TERMINATED
- Phase
- PHASE2
Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- NA
Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pilot Study of Unrelated Cord Blood Transplantation
- Status
- TERMINATED
- Phase
- PHASE2